PER 0.00% 10.0¢ percheron therapeutics limited

Ann: Phase IIb study of ATL1102 in DMD completes recruitment, page-133

  1. 13,350 Posts.
    lightbulb Created with Sketch. 1429
    In this case
    “no news is good news”
    Everything is ticking along
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.